Ad
AKAO - Achaogen Stock Trading
About | Achaogen (NASDAQ:AKAO)
Not available
Quote | Achaogen (NASDAQ:AKAO)
| Last: | $ |
|---|---|
| Change Percent: | 2.23% |
| Open: | $0.106 |
| Close: | $0.11 |
| High: | $0.19 |
| Low: | $0.102 |
| Volume: | 47,627,225 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Achaogen (NASDAQ:AKAO)
-
Antibiotics maker, Paratek Pharmaceuticals ( PRTK ), has struggled to hold onto gains in 2019. The has been a recent setback in the clinic but success on the funding front, both of which are worth discussing and the first focus of this article. Secondly, I look forward to a potential catalys...
-
Recently in the journal Nature , an article was published characterizing the oldest known example of a fungus. The organism, termed an Ourasphaira, was approximately one billion years old and was found in what was believed to be an ancient river bed in Canada. For comparison sake, the oldes...
Message Board Posts | Achaogen (NASDAQ:AKAO)
| Subject | By | Source | When |
|---|---|---|---|
| No posts yet. | |||
Ad
-
SOUTH SAN FRANCISCO, Calif., June 06, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced today it has reached agreements to sell substan...
-
SOUTH SAN FRANCISCO, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced today that it has filed a volun...
-
-- ZEMDRI’s once-daily 30-minute infusion facilitating usage in the outpatient setting -- -- Company’s recent restructuring aimed at conserving capital to continue assessment of strategic alternatives -- -- Conference call today at 4:30 p.m. Eastern Time -- SOUTH S...